Pharmaceutical Industry Blog

Last Updated: July 20, 2026 TL;DR: Saudi Arabia — a market of roughly 35 million people, more than 40% of them expatriates, accounting for around 60% of GCC healthcare expenditure and pharmaceutical purchasing — is regulated by one of the most capable authorities in the region. The Saudi Food and Drug Authority reached WHO Global Benchmarking Tool Maturity Level 4 in October 2023, the first in the Eastern Mediterranean Region and third worldwide to do so. Marketing authorisat

Last Updated: July 20, 2026 TL;DR: Malaysia — a 34.4 million-population upper-middle-income market served by roughly 149 Ministry of Health hospitals and more than 200 licensed private hospitals — runs one of the more demanding medicine regulatory systems in Southeast Asia, and any injectable supplier that treats it casually will not get through the door. Product registration is granted by the Drug Control Authority (DCA) on the technical assessment of the National Pharmaceut

Last Updated: July 19, 2026 TL;DR: Ghana — a West African healthcare market served by a four-tier public network of teaching hospitals (Korle Bu, Komfo Anokye and Tamale), regional hospitals, district hospitals and CHPS compounds, financed in large part through the National Health Insurance Scheme — carries a dual disease burden of malaria, tuberculosis, cholera and diarrhoeal illness alongside non-communicable diseases that now account for an estimated 43% of deaths, and tha

Last Updated: July 19, 2026 TL;DR: Uzbekistan — Central Asia's most populous country, served by a Ministry of Health network that runs from republican specialised scientific-practical medical centres in Tashkent through regional (viloyat) multidisciplinary medical centres to district hospitals and rural physician points — imports more than 80% of the medicines its patients use, which puts a permanent premium on reliable, compliant sterile injectable supply. Every medicine pla

Last Updated: July 18, 2026 TL;DR: Mozambique — a nation of around 35 million people whose predominantly public health system reaches from central hospitals in Maputo, Beira, Nampula and Quelimane down to provincial and district hospitals and a wide network of health centres, and which imports the large majority of its finished medicines and almost all of its active pharmaceutical ingredients — depends on a reliable, compliant supply of sterile injectables. Every imported ste

Last Updated: July 18, 2026 TL;DR: Ukraine — one of Europe's largest countries by area, home to tens of millions of people and served by a Ministry of Health system that runs from national specialist institutes and oblast (regional) hospitals in Kyiv, Lviv, Dnipro, Kharkiv and Odesa down to city, rayon and community hospitals and a reformed primary-care network — depends on a reliable, compliant supply of sterile injectables, with demand weighted heavily toward emergency, tra